Skip to main content
Vai all'homepage della Commissione europea (si apre in una nuova finestra)
italiano it
CORDIS - Risultati della ricerca dell’UE
CORDIS

Thermoresponsive and mucoadhesive nanogels for intramammary administration of antimicrobial compounds to be employed in bovine mastitis treatment

Descrizione del progetto

Una soluzione intelligente di somministrazione controllata dei farmaci per combattere la mastite bovina

La mastite bovina è la malattia più diffusa nelle mucche da latte ed è responsabile di ingenti perdite economiche nell’industria lattiero-casearia a livello mondiale. I batteri patogeni responsabili della malattia si convertono in forme intracellulari e biopellicole in modo da rimanere all’interno della ghiandola mammaria ed eludere le terapie antibiotiche e la risposta immunitaria dell’ospite. Per affrontare questo problema, il progetto THERMUCNA, finanziato dall’UE, si propone di sviluppare nanogel intelligenti per convogliare gli agenti antimicrobici all’interno delle ghiandole mammarie delle mucche infette e curare la mastite bovina. Questi idrogel saranno progettati in modo da penetrare le biopellicole batteriche e rilasciare la dose minima efficace di farmaco in seguito a stimolazione termica. Bloccare i meccanismi virulenti sviluppati dai patogeni è fondamentale per la loro eradicazione. Inoltre, la riduzione dell’esposizione agli antimicrobici contribuisce a ridurre al minimo la farmacoresistenza.

Obiettivo

Bovine mastitis (BM) is the most prevalent disease that affects dairy cows in many countries and it is the most important cause of economic losses in the dairy industry worldwide. The dairy activity is very important for the European economy, producing nearly a quarter of the world’s available milk. Currently, BM control consists mainly of antibiotic therapies. However, they usually cannot eradicate the infection due to acquired drug resistance and survival strategies of bacteria. The mechanisms developed by pathogens are intracellular and biofilm lifestyles that allow them to persist in the mammary gland protected from antibiotic therapies and host immune response. So new therapeutic approaches are needed. The present research project proposes the employment of smart nanogels (NGs) for antimicrobial delivery into mammary gland for BM treatment. The synthesized NGs will present: (i) nanometer size; (ii)thermoresponsive behavior: thermally triggered drug release; (iii) disulfides in their structure: mucoadhesive trigger upon the mucosal environment; (iv) modulated positive charge which will improve their penetration into bacteria biofilms. Several polymers and crosslinker agents will be evaluated to obtain a series of NGs. Defensin 5 and ceftiofur will be studied as antimicrobial agents to entrap into NGs. The virulence mechanisms developed by bacteria are the main responsible for the failure of antimicrobial treatments. Therefore, NGs will be studied and characterized to find suitable nanocarriers with the ability to penetrate bacterial biofilms and internalize host cells, blocking the virulence mechanisms developed by pathogens. Also, the smart drug release lets ensure that the exposition of the host to antimicrobial will be minimum and necessary to kill bacteria. This fact contributes to reducing bacterial resistance development. Nanotechnology in BM treatment is poorly explored which highlight the novelty of the research project proposed.

Campo scientifico (EuroSciVoc)

Parole chiave

Programma(i)

Argomento(i)

Meccanismo di finanziamento

MSCA-IF - Marie Skłodowska-Curie Individual Fellowships (IF)

Vedi tutti i progetti finanziati nell’ambito di questo schema di finanziamento

Invito a presentare proposte

(si apre in una nuova finestra) H2020-MSCA-IF-2019

Vedi tutti i progetti finanziati nell’ambito del bando

Coordinatore

UNIVERSIDAD DEL PAIS VASCO/ EUSKAL HERRIKO UNIBERTSITATEA
Contributo netto dell'UE
€ 172 932,48
Indirizzo
BARRIO SARRIENA S N
48940 Leioa
Spagna
Regione
Noreste País Vasco Bizkaia
Tipo di attività
Higher or Secondary Education Establishments
Collegamenti
Costo totale
€ 172 932,48